首页> 外文期刊>World Journal of Gastroenterology >Influence of serum collected from rat perfused with compound Biejiaruangan drug on hepatic stellate cells
【24h】

Influence of serum collected from rat perfused with compound Biejiaruangan drug on hepatic stellate cells

机译:复方别家软肝灌流大鼠血清对肝星状细胞的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To observe the effect of compound Biejiaruangan decoction (CBJRGC) (composite prescription of Carapax trionycis for softening the liver) on proliferation, activation, excretion of collagen and cytokine of hepatic stellate cells (HSCs) and to find the mechanism of prevention and treatment of hepatic fibrosis by CBJRGC. METHODS: Using MTT, immunohistochemistry and image analysis technology, the related indexes for proliferation, activation, excretion of collagen and cytokine of hepatic stellate cells were detected in 24 h, 48 h, and 72 h after adminstration of different dosages of CBJRGC. RESULTS: Statistical analysis showed that serum collected from rat perfused with CBJRGC could restrain the proliferation of HSC in 48 h and 72 h especially in high and medium dosage groups, markedly decrease the expression of desmin, synapsin and platelet derived growth factor (PDGF) in HSC in 24 h, 48 h and 72 h, as well as the expression of α-SMA, collagen Ⅲ, TIMP and TGFβ1 in 48 h and 72 h, decrease the excretion of collagen Ⅰ in 72 h. CBJRGC serum had no significant effect on collagens Ⅰ, Ⅲ and TIMP in 24 h. CONCLUSION: CBJRGC serum has a good curative effect on hepatic fibrosis. Its main mechanism may be related to the following factors. The drug serum can restrain the proliferation and activation of HSC, decrease the number of activated HSC and the total number of HSC, the excretion of collagens Ⅰ, Ⅲ, enhance the degradation of collagen and restore the balance of synthesis and degradation of collagen, inhibit the expression of transforming growth factor β1 (TGFβ1) and platelet derived growth factor (PDGF) in HSC, block and delay the process of hepatic fibrosis. Synapsin is a new marker of activation of HSC, which provides a theoretical and testing basis for neural regulation in the developing process of hepatic fibrosis.
机译:目的:观察复方B甲软肝汤(Capax trionycis复方软化肝脏的处方)对肝星状细胞(HSCs)增殖,活化,排泄的胶原蛋白和细胞因子的作用,并寻找预防和治疗的机制CBJRGC对肝纤维化的治疗方法:采用MTT,免疫组织化学和图像分析技术,在不同剂量的CBJRGC给药后24、48和72小时,检测肝星状细胞增殖,活化,胶原和细胞因子的相关指标。结果:统计学分析表明,灌流CBJRGC的大鼠血清可以抑制HSC在48h和72h的增殖,特别是在高,中剂量组,显着降低结蛋白,突触素和血小板衍生生长因子(PDGF)的表达。 24h,48h和72h的HSC,以及48h和72h的α-SMA,Ⅲ型胶原,TIMP和TGFβ1的表达降低72小时Ⅰ型胶原的排泄。 CBJRGC血清在24 h内对Ⅰ,Ⅲ型胶原和TIMP无影响。结论:CBJRGC血清对肝纤维化有良好的治疗作用。其主要机制可能与以下因素有关。药物血清可抑制HSC的增殖和活化,减少活化的HSC的数目和HSC的总数,Ⅰ,Ⅲ型胶原蛋白的排泄,促进胶原蛋白的降解,恢复胶原蛋白的合成和降解的平衡,抑制转化生长因子β1(TGFβ1)和血小板衍生生长因子(PDGF)在HSC中的表达,阻断和延缓肝纤维化的进程。突触蛋白是HSC激活的新标志物,为肝纤维化发展过程中的神经调节提供理论和测试基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号